THE OVARIAN CANCER RESEARCH FUND INC
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$38,070,603
Investments
87%
Cash & Equivalents
8%
Receivables (Non-Related)
3%
Other Assets
1%
Property, Plant, & Equipment (net)
<1%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$14,914,782
Grants Payable
95%
Other Liabilities
3%
Payables & Accruals
2%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$3,782,283
$3,156,704
-17%
Receivables (Non-Related)
$669,631
$1,212,071
+81%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$112,347
$69,269
-38%
Investments
$34,459,485
$33,033,627
-4%
Property, Plant, & Equipment (net)
$2,375
$80,000
+3268%
Other Assets
$177,236
$518,932
+193%
Total Assets
$39,203,357
$38,070,603
-3%
Liabilities
2023
2024
Change
Payables & Accruals
$247,245
$361,274
+46%
Grants Payable
$14,388,180
$14,132,020
-2%
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$84,868
$421,488
+397%
Total Liabilities
$14,720,293
$14,914,782
+1%
Net assets
2023
2024
Change
Restricted Net Assets
$10,793,328
$12,948,381
+20%
Unrestricted Net Assets
$13,689,736
$10,207,440
-25%
Net assets
2023
2024
Change
Net assets
+$24,483,064
+$23,155,821
-5%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)